DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

Citigroup Reinstates Neutral on Myovant Sciences, Announces $15 Price Target

Citigroup reinstates Myovant Sciences (NYSE:MYOV) with a Neutral and announces $15 price target.

Benzinga · 02/03/2020 11:38

Citigroup reinstates Myovant Sciences (NYSE:MYOV) with a Neutral and announces $15 price target.